Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Cited by (1,000)

Items 101–200 of 1,000

1. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
   Baijun Dong, Juju Miao, Yanqing Wang, Wenqin Luo, Zhongzhong Ji, Huadong Lai, Man Zhang, Xiaomu Cheng, Jinming Wang, Yuxiang Fang et al. · 2020 · Communications Biology
2. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery
   Ian R. Powley, Meeta Patel, Gareth J. Miles, Howard Pringle, Lynne M. Howells, Anne Thomas, Catherine A. Kettleborough, Justin S. Bryans, Tim R. Hammonds, Marion MacFarlane et al. · 2020 · British Journal of Cancer
3. Bioengineering Approaches for the Advanced Organoid Research
   Yi, Sang Ah, Zhang, Yixiao, Rathnam, Christopher, Pongkulapa, Thanapat, Lee, Ki‐Bum · 2021 · Advanced Materials
4. Stem cell-derived organoids and their application for medical research and patient treatment
   Sina Bartfeld, Hans C. Clevers · 2017 · Journal of Molecular Medicine
5. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology
   Lucie Thorel, Marion Perréard, Romane Florent, Jordane Divoux, Sophia Coffy, Audrey Vincent, Cédric Gaggioli, Géraldine Guasch, Xavier Gidrol, Louis‐Bastien Weiswald et al. · 2024 · Experimental & Molecular Medicine
6. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture
   Fanny Grillet, Elsa Bayet, Olivia Villeronce, Luke Zappia, Ebba L. Lagerqvist, Sebastian Lunke, Emmanuelle Charafe‐Jauffret, Kym Pham, Christina Mølck, Nathalie Rolland et al. · 2016 · Gut
7. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing
   Fadi Jacob, Guo‐li Ming, Hongjun Song · 2020 · Nature Protocols
8. Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity
   Ling Li, Hildur Knútsdóttir, Ken Hui, Matthew John Weiss, Jin Peng He, Benjamin Philosophe, Andrew MacGregor Cameron, Christopher L. Wolfgang, Timothy Michael Pawlik, Gabriel Ghiaur et al. · 2019 · JCI Insight
9. Clinical applications of human organoids
   Monique M. A. Verstegen, Robert Paul Coppes, Anne Béghin, Paolo De Coppi, M Gerli, Nienke de Graeff, Qiuwei Pan, Yoshimasa Saito, Shaojun Shi, AMIR ABBAS ZADPOOR et al. · 2025 · Nature Medicine
10. Modeling Pancreatic Cancer with Organoids
    Lindsey A. Baker, Hervé Tiriac, Hans C. Clevers, David A. Tuveson · 2016 · Trends in cancer
11. DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
    Lukas Perkhofer, Johann Gout, Élodie Roger, Fernando Kude de Almeida, Carolina Simões, Lisa Wiesmüller, Thomas Theodor Werner Seufferlein, Alexander Kleger · 2020 · Gut
12. HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
    Y. Wang, Tao Jiang, Zhongjun Qin, J. Jiang, Qiang Wang, S. Yang, Christopher J. Rivard, Guangcan Gao, T.L. Ng, Megan M. Tu et al. · 2018 · Annals of Oncology
13. Mini-Gut Organoids: Reconstitution of the Stem Cell Niche
    Shoichi Date, Toshiro Sato · 2015 · Annual Review of Cell and Developmental Biology
14. PTEN deficiency and AMPK activation promote nutrient scavenging and anabolism in prostate cancer cells
    Kim, Seong M., Nguyen, Tricia T., Ravi, Archna, Kubiniok, Peter, Finicle, Brendan T., Jayashankar, Vaishali, Malacrida, Leonel, Hou, Jue, Robertson, Jane, Gao, Dong et al. · 2018 · Cancer Discovery
15. SPOP mutation drives prostate tumorigenesis in vivo through coordinate regulation of PI3K/mTOR and AR signaling
    Blattner, Mirjam, Liu, Deli, Robinson, Brian D., Huang, Dennis, Poliakov, Anton, Gao, Dong, Nataraj, Srilakshmi, Deonarine, Lesa D., Augello, Michael A., Sailer, Verena et al. · 2017 · Cancer Cell
16. Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
    Neel Shah, Ping Wang, John Wongvipat, Wouter R. Karthaus, Wassim M. Abida, Joshua Armenia, Shira Rockowitz, Yotam Drier, B Bernstein, Henry W. Long et al. · 2017 · eLife
17. A Pharmacogenomic Landscape in Human Liver Cancers
    Zhixin Qiu, Hong Li, Zhengtao Zhang, Zhenfeng Zhu, Sheng He, Xujun Wang, Pengcheng Wang, Jianjie Qin, Liping Zhuang, Wei Wang et al. · 2019 · Cancer Cell
18. Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
    Julia Jabs, Franziska Maria Zickgraf, Jeongbin Park, Steve Wagner, Xiaoqi Jiang, Katharina Jechow, Kortine Kleinheinz, Umut H. Toprak, Marc Andre Schneider, Michael A. Meister et al. · 2017 · Molecular Systems Biology
19. Patient‐Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy
    Shaobo Mo, Peiyuan Tang, Wenqin Luo, Long Zhang, Yaqi Li, Xiang Hu, Xiaoji Ma, Yikuan Chen, Yichao Bao, Xingfeng He et al. · 2022 · Advanced Science
20. Emerging organoid models: leaping forward in cancer research
    Fan, Han, Demirci, Utkan, Chen, Pu · 2019 · Journal of Hematology & Oncology
21. Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
    Isabel Coutinho, Tanya K. Day, Wayne D. Tilley, Luke A. Selth · 2016 · Endocrine Related Cancer
22. Emerging Variants of Castration-Resistant Prostate Cancer
    Panagiotis J. Vlachostergios, Loredana Puca, Himisha Beltran · 2017 · Current Oncology Reports
23. Precision Oncology: The Road Ahead
    Daniela Senft, Mark D.M. Leiserson, Eytan Ruppin, Ze’ev A. Ronai · 2017 · Trends in Molecular Medicine
24. Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models
    Maenhoudt, Nina, Defraye, Charlotte, Boretto, Matteo, Jan, Ziga, Heremans, Ruben, Boeckx, Bram, Hermans, Florian, Arijs, Ingrid, Cox, Benoit, Van Nieuwenhuysen, Els et al. · 2020 · Stem Cell Reports
25. Organoid models of gastrointestinal cancers in basic and translational research
    Harry Cheuk-Hay Lau, Onno Kranenburg, Haipeng Xiao, Jun Yu · 2020 · Nature Reviews Gastroenterology & Hepatology
26. Mechanobiology of Tumor Growth
    Parthiv Kant Chaudhuri, Boon Chuan Low, Chwee Teck Lim · 2018 · Chemical Reviews
27. Use and application of 3D-organoid technology
    Benedetta Artegiani, Hans C. Clevers · 2018 · Human Molecular Genetics
28. ONECUT2 Is a Targetable Master Regulator of Lethal Prostate Cancer That Suppresses the Androgen Axis
    Mirja Rotinen, Sungyong You, Julie Yang, Simon G. Coetzee, Mariana Reis-Sobreiro, Wen‐Chin Huang, Fangjin Huang, Xinlei Pan, Alberto Yáñez, Dennis J. Hazelett et al. · 2018 · Nature Medicine
29. Applications of organoids for cancer biology and precision medicine
    Lo, Yuan-Hung, Karlsson, Kasper, Kuo, Calvin J. · 2020 · Nature Cancer
30. Promises and challenges of organoid-guided precision medicine
    Bose, Shree, Clevers, Hans, Shen, Xiling · 2021 · Med
31. Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer
    Miguel Reina‐Campos, Juan F. Linares, Ángeles Durán, Thekla Cordes, Antoine L’Hermitte, Mehmet G. Badur, Munveer Singh Bhangoo, Phataraporn K. Thorson, Alicia C. Richards, Tarmo Rooslid et al. · 2019 · Cancer Cell
32. Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies
    Luc Magré, Monique M. A. Verstegen, Sonja I. Buschow, Luc J. W. van der Laan, Maikel Petrus Peppelenbosch, Jyaysi Desai · 2023 · Journal for ImmunoTherapy of Cancer
33. Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine
    Hanxiao Xu, Ying Jiao, Shuang Qin, Weiheng Zhao, Qian Chu, Kongming Wu · 2018 · Experimental Hematology and Oncology
34. Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?
    Olga A. Martin, Robin L. Anderson, Kailash Narayan, Michael Patrick MacManus · 2016 · Nature Reviews Clinical Oncology
35. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells
    Beatrice Xuan Ho, Nicole Min Qian Pek, Boon-Seng Soh · 2018 · International Journal of Molecular Sciences
36. Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future
    Dilara Akhoundova, Mark A. Rubin · 2022 · Cancer Cell
37. A framework for understanding and targeting residual disease in oncogene-driven solid cancers
    Trever Grant Bivona, Robert Charles Doebele · 2016 · Nature Medicine
38. Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
    Takeshi Namekawa, Kazuhiro Ikeda, Kuniko Horie‐Inoue, Satoshi Inoue · 2019 · Cells
39. Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study
    Berend Snijder, Gregory Ian Vladimer, Nikolaus Krall, Katsuhiro Miura, Ann-Sofie Schmolke, Christoph Kornauth, Oscar Lopez de la Fuente, Hye-Soo Choi, Emiel van der Kouwe, Sinan Gültekin et al. · 2017 · The Lancet Haematology
40. FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer
    Han, Ming, Li, Fei, Zhang, Yehan, Dai, Pengfei, He, Juan, Li, Yunguang, Zhu, Yiqin, Zheng, Junke, Huang, Hai, Bai, Fan et al. · 2022 · Cancer Cell
41. Patient-derived tumor organoids for prediction of cancer treatment response
    Peter W. Nagle, John Th. M. Plukker, Christina T. Muijs, Peter van Luijk, Robert Paul Coppes · 2018 · Seminars in Cancer Biology
42. Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy
    Jialang Zhuang, Jizhou Tan, Chenglin Wu, Jie Zhang, Ting Liu, Chunhai Fan, Jiaping Li, Yuanqing Zhang · 2020 · Nucleic Acids Research
43. Tumor heterogeneity: preclinical models, emerging technologies, and future applications
    Marco Proietto, Martina Crippa, Chiara Damiani, Valentina Pasquale, Elena Sacco, Marco Vanoni, Mara Gilardi · 2023 · Frontiers in Oncology
44. Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device
    Khoo, Bee Luan, Grenci, Gianluca, Lim, Ying Bena, Lee, Soo Chin, Han, Jongyoon, Lim, Chwee Teck · 2018 · Nature Protocols
45. Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells
    Joshua M. Jackson, Malgorzata Anna Witek, Joyce W. Kamande, Steven A. Soper · 2017 · Chemical Society Reviews
46. Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer
    Hanling Wang, Ni Li, Qiuli Liu, Jiacheng Guo, Qiang Pan‐Hammarström, Bisheng Cheng, Junyu Xu, Baijun Dong, Guanjie Yang, Bin Yang et al. · 2023 · Cancer Cell
47. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
    Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, Jacob George, Liang Qiao · 2024 · Cancer Gene Therapy
48. Enteroid Monolayers Reveal an Autonomous WNT and BMP Circuit Controlling Intestinal Epithelial Growth and Organization
    Curtis A. Thorne, Ina W. Chen, Laura E. Sanman, Melanie H. Cobb, Lani F. Wu, Steven J. Altschuler · 2018 · Developmental Cell
49. Mouse models of colorectal cancer: Past, present and future perspectives
    Florian Bürtin, Christina Susanne Mullins, Michael Linnebacher · 2020 · World Journal of Gastroenterology
50. Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
    Zeda Zhang, Chuanli Zhou, Xiaoling Li, Spencer D. Barnes, Su Deng, Elizabeth Hoover, Chi-Chao Chen, Young Sun Lee, Yanxiao Zhang, Choushi Wang et al. · 2020 · Cancer Cell
51. Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases
    Masayuki Fujii, Toshiro Sato · 2020 · Nature Materials
52. Patient-derived xenografts and organoids model therapy response in prostate cancer
    Sofia Karkampouna, Federico La Manna, Andrej Benjak, Mirjam Kiener, Marta De Menna, Eugenio Zoni, Joël Grosjean, Irena Klima, Andrea Garofoli, Marco Bolis et al. · 2021 · Nature Communications
53. Efficient Use of Patient-Derived Organoids as a Preclinical Model for Gynecologic Tumors
    Maru, Yoshiaki, Tanaka, Naotake, Itami, Makiko, Hippo, Yoshitaka · 2019 · Gynecologic Oncology
54. Patient-derived organoids in precision cancer medicine
    Le Tong, Weiyingqi Cui, Boya Zhang, Pedro Fonseca, Qian Cheng Zhao, Ping Zhang, Beibei Xu, Qisi Zhang, Zhen Li, Brinton A. Seashore-Ludlow et al. · 2024 · Med
55. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy
    Jingjing Qu, Farhin Shaheed Kalyani, Li Liu, Tianli Cheng, Lijun Chen · 2021 · 癌症：英文版
56. Patient-derived induced pluripotent stem cells in cancer research and precision oncology
    Eirini P. Papapetrou · 2016 · Nature Medicine
57. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases
    Ludovica Grassi, Romina Alfonsi, Federica Francescangeli, Michele Signore, Maria Laura De Angelis, Antonio Addario, Manuela Costantini, Elisabetta Flex, Andrea Ciolfi, Simone Pizzi et al. · 2019 · Cell Death and Disease
58. Organoid cultures for cancer modeling
    Helen H.N. Yan, April Chan, Frank Pui-Ling Lai, Suet Yi Leung · 2023 · Cell stem cell
59. Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance
    Su Deng, Choushi Wang, Yunguan Wang, Yaru Xu, Xiaoling Li, Nickolas A. Johnson, Atreyi Mukherji, U‐Ging Lo, Lingfan Xu, Julisa Gonzalez et al. · 2022 · Nature Cancer
60. Heralding a new paradigm in 3D tumor modeling
    Eliza Li Shan Fong, Daniel A. Harrington, Mary C. Farach‐Carson, Hanry Yu · 2016 · Biomaterials
61. Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer
    Alba Cristobal, Henk van den Toorn, Marc van de Wetering, Hans C. Clevers, Albert J. R. Heck, Shabaz Mohammed · 2017 · Cell Reports
62. Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine
    Zarema Gilazieva, Aleksei S. Ponomarev, Catrin Sian Rutland, Albert Anatolyevich Rizvanov, Valeriya V. Solovyeva · 2020 · Cancers
63. Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy
    Bee Luan Khoo, Soo Chin Lee, Prashant Kumar, Tuan Zea Tan, Majid Ebrahimi Warkiani, Samuel G.W. Ow, Sayantani Nandi, Chwee Teck Lim, Jean Paul Thiery · 2015 · Oncotarget
64. In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening
    Andrea R. Mazzocchi, Shiny Amala Priya Rajan, Konstantinos Ioannis Votanopoulos, Adam R. Hall, Aleksander Skardal · 2018 · Scientific Reports
65. Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells
    Takashi Kijima, Hiroshi Nakagawa, Masataka Shimonosono, Prasanna Modayur Chandramouleeswaran, Takeo Hara, Varun Sahu, Yuta Kasagi, Osamu Kikuchi, Koji Tanaka, Véronique Giroux et al. · 2018 · Cellular and Molecular Gastroenterology and Hepatology
66. Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
    Ugo Testa, Germana Castelli, Elvira Pelosi · 2019 · Medicines
67. Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer
    John K. Lee, Nathanael Joshua Bangayan, Timothy Chai, Bryan A. Smith, Tiffany E. Pariva, Sangwon Yun, Ajay Amar Vashisht, Qingfu Zhang, Jung Wook Park, Eva Corey et al. · 2018 · Proceedings of the National Academy of Sciences
68. Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment
    Khoo, Bee Luan, Grenci, Gianluca, Jing, Tengyang, Lim, Ying Bena, Lee, Soo Chin, Thiery, Jean Paul, Han, Jongyoon, Lim, Chwee Teck · 2016 · Science Advances
69. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine
    Prakash Priyadarshi Praharaj, Sujit K. Bhutia, Sunitha Nagrath, Rhonda Lynn Bitting, Gagan Deep · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
70. The molecular and cellular origin of human prostate cancer
    John R. Packer, Norman J. Maitland · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
71. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures
    Karsten Boehnke, Philip W. Iversen, Dirk Schumacher, Marı́a José Lallena, Rubén Haro, Joaquín Amat, Johannes Haybaeck, Sandra Liebs, Martin Lange, Reinhold Schäfer et al. · 2016 · SLAS DISCOVERY
72. Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer
    Tong, Xinyuan, Patel, Ayushi S., Kim, Eejung, Li, Hongjun, Chen, Yueqing, Li, Shuai, Liu, Shengwu, Dilly, Julien, Kapner, Kevin S., Zhang, Ningxia et al. · 2024 · Cancer Cell
73. 3D Cell Cultures: Evolution of an Ancient Tool for New Applications
    Andrea Cacciamali, Riccardo Villa, Silvia Dotti · 2022 · Frontiers in Physiology
74. Drug discovery in advanced prostate cancer: translating biology into therapy
    Timothy Anthony Yap, Alan David Smith, Roberta Ferraldeschi, Bissan Al‐Lazikani, Paul Workman, Johann Sebastian De Bono · 2016 · Nature Reviews Drug Discovery
75. Human Cardiac Organoids for Disease Modeling
    Bramasta Nugraha, Michele F. Buono, Lisa von Boehmer, Simon Philipp Hoerstrup, Maximilian Y. Emmert · 2018 · Clinical Pharmacology & Therapeutics
76. Translational applications of adult stem cell-derived organoids
    Jarno Drost, Hans C. Clevers · 2017 · Development
77. Biomaterials‐Based Approaches to Tumor Spheroid and Organoid Modeling
    Pradip Shahi Thakuri, Chun Liu, Gary D. Luker, Hossein Tavana · 2017 · Advanced Healthcare Materials
78. Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations
    Francesc Castro-Giner, Sofia Gkountela, Cinzia Donato, Ilaria Alborelli, Luca Quagliata, Charlotte K.Y. Ng, Salvatore Piscuoglio, Nicola Aceto · 2018 · Diagnostics
79. Organoid based personalized medicine: from bench to bedside
    Yaqi Li, Peiyuan Tang, Sanjun Cai, Junjie Peng, Guoqiang Hua · 2020 · Cell Regeneration
80. Patient-derived organoid (PDO) platforms to facilitate clinical decision making
    Lisa Liu, Lei Yu, Zhichao Li, Wujiao Li, Weiren Huang · 2021 · Journal of Translational Medicine
81. Kidney Organoids: A Translational Journey
    Ryuji Morizane, Joseph Vincent Bonventre · 2017 · Trends in Molecular Medicine
82. Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips
    Wangxin Guo, Lin Li, Juan He, Zhuang Liu, Ming Han, Fei Li, Xinyi Xia, Xiaoyu Zhang, Yao Zhu, Wei Yu et al. · 2020 · Nature Genetics
83. Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures
    Niklas K. Finnberg, Prashanth Ravishankar Gokare, Avital Lev, Sergei I. Grivennikov, Alexander W. Macfarlane, Kerry S. Campbell, Ryan M. Winters, Karen Kaputa, Jeffrey M. Farma, Abbas E. Abbas et al. · 2017 · Oncotarget
84. Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
    Zhichao Li, Youhui Qian, Wujiao Li, Lisa Liu, Lei Yu, Xia Liu, Guodong Wu, Youyu Wang, Weibin Luo, Fuyuan Fang et al. · 2020 · iScience
85. Multi-Organs-on-Chips: Towards Long-Term Biomedical Investigations
    Yi Zhao, Ranjith Kumar Kankala, Shi‐Bin Wang, Ai‐Zheng Chen · 2019 · Molecules
86. Glycans as Biomarkers in Prostate Cancer
    Emma Scott, Jennifer Munkley · 2019 · International Journal of Molecular Sciences
87. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient
    Theresa Mulholland, Milly J McAllister, Samantha Patek, David Flint, Mark Underwood, Alexander Sim, Joanne Edwards, Michele Zagnoni · 2018 · Scientific Reports
88. Recent Advances in Microfluidic Platforms Applied in Cancer Metastasis: Circulating Tumor Cells' (CTCs) Isolation and Tumor‐On‐A‐Chip
    Zhengjie Lin, Guanyi Luo, Weixiang Du, Tiantian Kong, Changkun Liu, Zhou Liu · 2019 · Small
89. Loss and revival of androgen receptor signaling in advanced prostate cancer
    Nicolò Formaggio, Mark A. Rubin, Jean-Philippe Paul. Theurillat · 2021 · Oncogene
90. Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids
    Prince, Elisabeth, Cruickshank, Jennifer, Ba-Alawi, Wail, Hodgson, Kelsey, Haight, Jillian, Tobin, Chantal, Wakeman, Andrew, Avoulov, Alona, Topolskaia, Valentina, Elliott, Mitchell J. et al. · 2022 · Nature Communications
91. Single‐Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids
    Yan Zhao, Zhixuan Li, Yanjing Zhu, Jing Fu, Xiaofang Zhao, Yani Zhang, Shan Wang, Jianmin Wu, Kaiting Wang, Rui Ting Wu et al. · 2021 · Advanced Science
92. Patient-Derived Cancer Organoids as Predictors of Treatment Response
    Maikel Verduin, Ann Hoeben, Dirk De Ruysscher, Marc Vooijs · 2021 · Frontiers in Oncology
93. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening
    Du, Yuhong, Li, Xingnan, Niu, Qiankun, Mo, Xiulei, Qui, Min, Ma, Tingxuan, Kuo, Calvin J, Fu, Haian · 2020 · Journal of Molecular Cell Biology
94. Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model
    Chang Qing Yang, Bai-Rong Xia, Weilin Jin, Ge Lou · 2019 · Cancer Cell International
95. Three-dimensional models for studying development and disease: moving on from organisms to organs-on-a-chip and organoids
    Emily Jackson, Hang Lu · 2016 · Integrative Biology
96. A patient‐derived explant ( PDE ) model of hormone‐dependent cancer
    Margaret M. Centenera, Theresa E. Hickey, Shalini Jindal, Natalie K. Ryan, Preethi Ravindranathan, Hisham Mohammed, Jessica L. L. Robinson, Matthew Joseph Schiewer, Shihong Ma, Payal Kapur et al. · 2018 · Molecular Oncology
97. CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
    Tanu Shenoy, Gunther Boysen, M.Y. Wang, Q.Z. Xu, Weilong Guo, Fong Ming Koh, C. Wang, L.Z. Zhang, Y. Wang, Veronica Gil et al. · 2017 · Annals of Oncology
98. CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs)
    Tala Tayoun, Vincent Faugeroux, Marianne Oulhen, Agathe Aberlenc, Patrycja Pawlikowska, Françoise Farace · 2019 · Cells
99. Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade
    Juan F. Linares, Ángeles Durán, Miguel Reina‐Campos, Pedro Aza‐Blanc, Alex Rosa Campos, Jorge Moscat, Maria Teresa Díaz-Meco · 2015 · Cell Reports
100. Concise Review: Prostate Cancer Stem Cells: Current Understanding
     Sergej Skvortsov, Ira Skvortsova, Dean G. Tang, Anna Dubrovska · 2018 · Stem Cells